Company profile: Flagship Biosciences
1.1 - Company Overview
Company description
- Provider of AI-enabled tissue profiling via the cTA pathology platform, offering SPATIALPlex spatial biology, Flagship Data Science for per-cell analysis integrating spatial proteomic/genomic data, multiplex IHC/FISH/CISH assay development and validation, genomics sequencing and gene expression, flow cytometry for hematopoietic neoplasms and immunophenotyping, and AI-driven digital pathology/image analysis.
Products and services
- Digital Pathology and Image Analysis: Utilizes proprietary AI software to architect customized deep-learning assemblies for pathology, generating tailored image analyses and tissue profiling outputs in a custom-engineered framework
- Flagship Data Science: Aggregates and interrogates data points per cell, unifying spatial proteomic and genomic datasets to yield actionable insights for therapeutic development via a research-grade analytics pipeline
- SPATIALPlex Solutions: Spatial biology platform integrating Flagship Biosciences scientists and bioinformaticians to deliver customized data for tissue profiling within an enterprise-grade program
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Flagship Biosciences
Luminex
HQ: United States
Website
- Description: Provider of flow cytometry and imaging, supported by commercial, operations, research and development, and support personnel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminex company profile →
Revenio Group
HQ: Finland
Website
- Description: Provider of ophthalmological devices and solutions, offering iCare intraocular pressure measurement devices (IC100 handheld; IC200 for multiple patient positions), TONOVET for veterinarians, HOME2 for home IOP monitoring with app data sharing, and fundus imaging systems including EIDON AF (true-color confocal, fully automated) and DRSplus (high-quality images from small pupils and through cataracts/media opacities).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Revenio Group company profile →
Biotecon Diagnostics
HQ: Germany
Website
- Description: Provider of innovative, rapid real-time PCR detection systems for pathogens, spoilage organisms, GMOs, and allergens, along with sample preparation kits under the foodproof and microproof product lines for molecular and microbiological methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotecon Diagnostics company profile →
Biosurfit
HQ: Portugal
Website
- Description: Provider of point-of-care and at-home diagnostic solutions, including spinit, a quantitative blood analysis platform for immunoassay, haematology and clinical chemistry; at-home lab testing with home sample collection; mylab.care clinical analyses, exams, consultations and nutrition advice; Pharmacare e-commerce for non-prescription drugs, supplements, self-tests and other health products; and contract design and manufacturing based on proprietary technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosurfit company profile →
HistoCyte Laboratories
HQ: United Kingdom
Website
- Description: Provider of cell line controls and services for immunohistochemistry and in situ hybridization in cancer diagnosis, offering pre-cut slides and cell microarray blocks, dynamic range and standard controls, custom cell line development, biomarker characterization and assessment, and proof-of-concept and feasibility studies to improve assay confidence and assess assay quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HistoCyte Laboratories company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Flagship Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Flagship Biosciences
2.2 - Growth funds investing in similar companies to Flagship Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Flagship Biosciences
4.2 - Public trading comparable groups for Flagship Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →